Skip to Main Content

Author Details

Aaron S Kesselheim
Brigham and Women's Hospital.
2001
683
55
PMIDPaper TitleJournal TitlePublished Year
38088900Identifying therapeutic alternatives in Medicare drug price negotiation: The case of etanercept.J Manag Care Spec Pharm2024
37801012Federal Enforcement of Pharmaceutical Fraud under the False Claims Act, 2006-2022.J Health Polit Policy Law2024
38010690Potential Medicare and Medicaid Savings on Anti-CD20 Therapy for Multiple Sclerosis.JAMA Neurol2024
38010643Cost of Exempting Sole Orphan Drugs From Medicare Negotiation.JAMA Intern Med2024
37904069Independent Advice on Drug Approvals: an Investigation of EMA Practices.J Gen Intern Med2024
38052268Rates and costs of drug testing practices for private payors in the outpatient setting in the United States, 2015-2019.J Subst Use Addict Treat2024
37735523Complicated regulatory decision-making following inconsistent trial results: the issue with ibrutinib for mantle cell lymphoma.Nat Rev Clin Oncol2024
37983047Why Some Patients Overpay for Specialty Generic Drugs.JAMA Intern Med2024
37873843Preserving Timely Generic Drug Competition with Legislation on "Skinny Labeling".Clin Pharmacol Ther2024
36227630Patient Out-of-Pocket Costs Following the Availability of Biosimilar Versions of Infliximab.Clin Pharmacol Ther2023
38079488Overcoming Challenges to Implementing New Evidence for Low-Dose Anticoagulant Use in Peripheral Artery Disease.Circulation2023
37962889National Comprehensive Cancer Network Guideline Recommendations of Cancer Drugs With Accelerated Approval.JAMA Netw Open2023
37526728Changes in the Number of Continuation Patents on Drugs Approved by the FDA.JAMA2023
37955942Inequitable Conduct and Invalidation of Patents Related to Food and Drug Administration-Regulated Products.JAMA2023
37655568Battles Over Medication Abortion Threaten the Integrity of Drug Approvals in the U.S.J Law Med Ethics2023
37549393Comparative Effectiveness and Safety of Generic Versus Brand-Name Fluticasone-Salmeterol to Treat Chronic Obstructive Pulmonary Disease.Ann Intern Med2023
37844306Regulatory Review Duration and Differences in Submission Times of Drugs in the United States and Europe, 2011 to 2020.Ann Intern Med2023
37694884The Accelerated Approval Program for Cancer Drugs - Finding the Right Balance.N Engl J Med2023
37581674Gauging the Value of Top-Selling Drugs in Medicare-Reply.JAMA2023
37505513Patents and Regulatory Exclusivities on GLP-1 Receptor Agonists.JAMA2023
37505512340B-Where Do We Go From Here?JAMA2023
37505487Authority of Medicare to Limit Coverage of FDA-Approved Products: Legal and Policy Considerations.JAMA Intern Med2023
37991784Outcomes of the 340B Drug Pricing Program: A Scoping Review.JAMA Health Forum2023
37935853Approval and therapeutic value of gene therapies in the US and Europe.Gene Ther2023
37682556Protecting Medicare's Discretion to Say No to Unproven Therapies.JAMA2023
37819215Will Medicare Price Negotiation Delay Cancer-Drug Launches?N Engl J Med2023
37603868The Regulatory Repercussions of Approving Muscular Dystrophy Medications on the Basis of Limited Evidence.Ann Intern Med2023
37971985Patents and regulatory exclusivities on FDA-approved insulin products: A longitudinal database study, 1986-2019.PLoS Med2023
37871317Changes in Induced Medical and Procedural Abortion Rates in a Commercially Insured Population, 2018 to 2022 : An Interrupted Time-Series Analysis.Ann Intern Med2023
37459615Moving Naloxone Over the Counter Is Necessary but Not Sufficient.Ann Intern Med2023
37218658Physician Perspectives on the Food and Drug Administration's Decision to Grant Accelerated Approval to Aducanumab for Alzheimer's Disease.Clin Pharmacol Ther2023
37159041Five-Year Sales for Newly Marketed Prescription Drugs With and Without Initial Orphan Drug Act Designation.JAMA2023
37452180The prevalence of drug patent term extensions in the United States, 2000-2018.Nat Biotechnol2023
37418270Association of Advisory Committee Votes With US Food and Drug Administration Decision-Making on Prescription Drugs, 2010-2021.JAMA Health Forum2023
37213116Chronic Obstructive Pulmonary Disease Exacerbations and Pneumonia Hospitalizations Among New Users of Combination Maintenance Inhalers.JAMA Intern Med2023
37410777The impact of electronic health record discontinuity on prediction modeling.PLoS One2023
37410756Physician experiences with and perceptions of risk evaluation and mitigation strategy programs with elements to assure safe use.PLoS One2023
37343194Ensuring Ethical Postprogression Therapy for Patients in Randomized Trial Control Arms.J Clin Oncol2023
37244690Concerns about climate activism in clinical practice - Authors' reply.Lancet2023
37407074Therapeutic value of first versus supplemental indications of drugs in US and Europe (2011-20): retrospective cohort study.BMJ2023
37276474Inflationary Rebates For Generic Drugs Sold Through Medicaid Saved Billions During 2017-20.Health Aff (Millwood)2023
37142342Melflufen: post-hoc subgroup analyses and the US FDA Oncologic Drugs Advisory Committee.Lancet Haematol2023
37467036Infections following bispecific antibodies in myeloma: a systematic review and meta-analysis.Blood Adv2023
37438124Variation in Endpoints in FDA Medication Approvals: A Review of Acute and Preventive Migraine Medications.Neurology2023
37272495An Empirical Review of Key Glucose Monitoring Devices: Product Iterations and Patent Protection.J Diabetes Sci Technol2023
37071095Added Therapeutic Benefit of Top-Selling Brand-name Drugs in Medicare.JAMA2023
37000434Timing of Confirmatory Trials for Drugs Granted Accelerated Approval Based on Surrogate Measures From 2012 to 2021.JAMA Health Forum2023
37433102High Cost of Chimeric Antigen Receptor T-Cells: Challenges and Solutions.Am Soc Clin Oncol Educ Book2023
37226746Transferable Exclusivity Vouchers and Incentives for Antimicrobial Development in the European Union.J Law Med Ethics2023
37126755Federal Funding For Discovery And Development Of Costly HIV Drugs Was Far More Than Previously Estimated.Health Aff (Millwood)2023
  • 1 - 50 of 683

Recommended Authors

Erica A Voss
Erasmus University Medical Center
Career Start Year 2014
Number of shared co-authors 1
Dalia Dawoud
Stanford University
Career Start Year 2010
Number of shared co-authors 2
Tim K Mackey
University of California San Diego
Career Start Year 2009
Number of shared co-authors 1
Carmel Shachar
Center for Health Law and Policy Innovation
Career Start Year 2008
Number of shared co-authors 3
Benjamin P Geisler
Massachusetts General Hospital, Harvard Medical School
Career Start Year 2008
Number of shared co-authors 0
Holly Fernandez Lynch
University of Pennsylvania Perelman School of Medicine.
Career Start Year 2007
Number of shared co-authors 9
Sengwee Toh
Harvard Medical School and Harvard Pilgrim Health Care Institute
Career Start Year 2006
Number of shared co-authors 7
Jeremy A Rassen
Brigham and Women's Hospital, Harvard Medical School
Career Start Year 2006
Number of shared co-authors 6
Ralph F Hall
University of Minnesota Law School
Career Start Year 2006
Number of shared co-authors 0
Jordan Paradise
Beazley Institute for Health Law and Policy, Loyola University Chicago School of Law
Career Start Year 2004
Number of shared co-authors 0
Christine Y Lu
Harvard Medical School and the Harvard Pilgrim Health Care Institute
Career Start Year 2004
Number of shared co-authors 2
Tania Bubela
Simon Fraser University
Career Start Year 2004
Number of shared co-authors 3
June M McKoy
Feinberg School of Medicine, Northwestern University
Career Start Year 2003
Number of shared co-authors 0
Jalpa A Doshi
University of Pennsylvania Perelman School of Medicine
Career Start Year 2002
Number of shared co-authors 0
Nilay D Shah
Mayo Clinic
Career Start Year 2002
Number of shared co-authors 7
Rebecca N Jerome
12328Vanderbilt University Medical Center
Career Start Year 2001
Number of shared co-authors 0
Carolyn Riley Chapman
Center for Human Genetics and Genomics, NYU Grossman School of Medicine
Career Start Year 1997
Number of shared co-authors 2
Arti K Rai
From Duke University School of Law
Career Start Year 1997
Number of shared co-authors 2
Emily Beth Devine
University of Washington
Career Start Year 1997
Number of shared co-authors 0
Christopher McCabe
Queens University Belfast
Career Start Year 1996
Number of shared co-authors 2
Jeffrey S Brown
Harvard Medical School and Harvard Pilgrim Health Care Institute
Career Start Year 1995
Number of shared co-authors 6
Dana P Goldman
University of Southern California
Career Start Year 1992
Number of shared co-authors 1
Paul M Coplan
Perelman School of Medicine, University of Pennsylvania
Career Start Year 1990
Number of shared co-authors 2
Robert S Epstein
Epstein Health LLC
Career Start Year 1988
Number of shared co-authors 0
Sean Tunis
Center for Evaluation of Value and Risk in Health, Tufts Medical Center
Career Start Year 1987
Number of shared co-authors 1
Charles L Bennett
University of South Carolina
Career Start Year 1986
Number of shared co-authors 2
Andy Stergachis
School of Pharmacy, University of Washington
Career Start Year 1980
Number of shared co-authors 1
Dennis W Raisch
The University of New Mexico
Career Start Year 1977
Number of shared co-authors 0
Stan N Finkelstein
University of Toronto
Career Start Year 1977
Number of shared co-authors 1
Brian L Strom
Center for Pharmacoepidemiology and Treatment Science, Rutgers University
Career Start Year 1970
Number of shared co-authors 1

Collaborators

Ameet Sarpatwari
Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital
Co-authored papers 84
Joshua J Gagne
Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital
Co-authored papers 42
Michael Fralick
University of Toronto
Co-authored papers 17
Eric G Campbell
Center for Bioethics and Humanities, University of Colorado School of Medicine
Co-authored papers 16
Joseph S Ross
Yale School of Medicine
Co-authored papers 14
Gerald J Dal Pan
Center for Drug Evaluation and Research
Co-authored papers 9
Michelle M Mello
Co-authored papers 9
Sebastian Schneeweiss
Division of Pharmacoepidemiology, Brigham & Women's Hospital, Harvard Medical School
Co-authored papers 8
Lisa M Schwartz
Co-authored papers 7
Steven Joffe
Medical Ethics and Health Policy, University of Pennsylvania
Co-authored papers 7
Florence T Bourgeois
Boston Children's Hospital
Co-authored papers 6
James R Rogers
Columbia University
Co-authored papers 4
Elisabetta Patorno
Harvard Medical School
Co-authored papers 4
Rishi J Desai
Harvard Medical School
Co-authored papers 4
Justin Bohn
Harvard Medical School and Harvard Pilgrim Health Care Institute
Co-authored papers 3
Nicholas S Downing
Center for Outcomes Research and Evaluation, Yale-New Haven Hospital
Co-authored papers 3
John S Brownstein
Boston Children's Hospital
Co-authored papers 3
Sanket S Dhruva
University of California san francisco
Co-authored papers 3
Jon Duke
Georgia Tech Research Institute, Georgia Tech College of Computing
Co-authored papers 2
Ivan Glenn Cohen
Petrie-Flom Center for Health Law Policy, Harvard University
Co-authored papers 2
David W Bates
Brigham and Women's Hospital Division of General Internal Medicine
Co-authored papers 2
Stacie B Dusetzina
Vanderbilt University School of Medicine, TN Vanderbilt Ingram Cancer Center
Co-authored papers 2
Shirley V Wang
Brigham and Women's Hospital, Harvard Medical School
Co-authored papers 2
Abraham G Hartzema
Co-authored papers 2
Lisa Soleymani Lehmann
Harvard Medical School
Co-authored papers 2
George Caleb Alexander
Institute of General Practice and Family Medicine, University Hospital
Co-authored papers 2
Robert Cook-Deegan
Arizona State University.
Co-authored papers 2
David J Clark
University of Florida
Co-authored papers 1
Hagop Kantarjian
The University of Texas MD Anderson Cancer Center
Co-authored papers 1
Per Olav Vandvik
Lovisenberg Diaconal Hospital
Co-authored papers 1
Release 1.2